EYEPOINT

Serial Number 88546557
Registration 6133661
700

Registration Progress

Application Filed
Jul 29, 2019
Under Examination
Approved for Publication
Jun 9, 2020
Published for Opposition
Jun 9, 2020
Registered
Aug 25, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-25)
Due: Aug 25, 2026 294 days

Trademark Image

EYEPOINT

Basic Information

Serial Number
88546557
Registration Number
6133661
Filing Date
July 29, 2019
Registration Date
August 25, 2020
Published for Opposition
June 9, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 25, 2020
Registration
Registered
Classes
005

Rights Holder

EyePoint Pharmaceuticals US, Inc.

03
Address
Suite C400
480 PLEASANT STREET, SUITE B300
WATERTOWN, MA 02472

Ownership History

EyePoint Pharmaceuticals US, Inc.

Original Applicant
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Owner at Publication
03
Watertown, MA

EyePoint Pharmaceuticals US, Inc.

Original Registrant
03
WATERTOWN, MA

Legal Representation

Attorney
Kimberly Jarman, Esq.

USPTO Deadlines

Next Deadline
294 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-25)
Due Date
August 25, 2026
Grace Period Ends
February 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
Aug 29, 2025 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Aug 25, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Oct 28, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 28, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Oct 28, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Oct 28, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Oct 28, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Aug 25, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 9, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 9, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 20, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Apr 30, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 28, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Apr 27, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 27, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 26, 2019 EPEN O COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY Loading...
Oct 26, 2019 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Oct 26, 2019 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Oct 26, 2019 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Oct 22, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 8, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 1, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
House mark for drug delivery agents consisting of polymer compounds that facilitate delivery of pharmaceutical preparations for the treatment of eye diseases and conditions; house mark for pharmaceutical preparations for ocular or intraocular surgery; house mark for pharmaceutical preparations for the treatment of ocular diseases and conditions
First Use Anywhere: Feb 28, 2019
First Use in Commerce: Feb 28, 2019

Additional Information

Pseudo Mark
EYE POINT

Classification

International Classes
005